Autopsy report · NCT00600262

Intravitreal Bevacizumab for Diabetic Retinopathy

“Undefined”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months after it had already started.
• Ran for about 6 months before it stopped.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Asociación para Evitar la Ceguera en México

Sponsor type

University, hospital or other

Conditions

Severe Nonproliferative; Proliferative Diabetic Retinopathy; Active Photocoagulated Diabetic Retinopathy

Interventions

intravitreal bevacizumab

Sites

1

Countries

Mexico

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.